Amin R, Vaishali K, Maiya G, Mohapatra A, Sinha M, Bhat A
F1000Res. 2024; 13:405.
PMID: 38895701
PMC: 11184280.
DOI: 10.12688/f1000research.147340.1.
Liu J, Wang F, Hong Y, Luo F
Heliyon. 2024; 10(8):e29266.
PMID: 38655311
PMC: 11036012.
DOI: 10.1016/j.heliyon.2024.e29266.
Yamamura K, Hara J, Watanabe S, Kobayashi T, Kase K, Takeda Y
J Thorac Dis. 2024; 16(3):2159-2166.
PMID: 38617783
PMC: 11009587.
DOI: 10.21037/jtd-23-1443.
Sanduzzi Zamparelli S, Lombardi C, Candia C, Iovine P, Rea G, Vitacca M
J Clin Med. 2024; 13(7).
PMID: 38610791
PMC: 11012394.
DOI: 10.3390/jcm13072026.
Wang H, Tsai S, Lin Y, Hou J, Chao C
BMC Pulm Med. 2024; 24(1):160.
PMID: 38566026
PMC: 10986056.
DOI: 10.1186/s12890-024-02947-5.
Referral rates and barriers to lung transplantation based on pulmonary function criteria in interstitial lung diseases: a retrospective cohort study.
Deri O, Ovadia D, Huszti E, Peled M, Saute M, Hod T
Ther Adv Respir Dis. 2024; 18:17534666231221750.
PMID: 38179653
PMC: 10771041.
DOI: 10.1177/17534666231221750.
The role of pulmonary rehabilitation in idiopathic pulmonary fibrosis: An overview of systematic reviews.
Song S, Feng Z, Liu W, Li J
PLoS One. 2023; 18(12):e0295367.
PMID: 38127914
PMC: 10734956.
DOI: 10.1371/journal.pone.0295367.
Home-Based Physiotherapy and Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis: A Review.
Celik M, Pehlivan E
Thorac Res Pract. 2023; 24(3):170-176.
PMID: 37503620
PMC: 10346104.
DOI: 10.5152/ThoracResPract.2023.22150.
Engineering Ferroptosis Inhibitors as Inhalable Nanomedicines for the Highly Efficient Treatment of Idiopathic Pulmonary Fibrosis.
Guo M, Peng T, Wu C, Pan X, Huang Z
Bioengineering (Basel). 2023; 10(6).
PMID: 37370658
PMC: 10295167.
DOI: 10.3390/bioengineering10060727.
Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks.
Patrucco F, Solidoro P, Gavelli F, Apostolo D, Bellan M
Microorganisms. 2023; 11(4).
PMID: 37110318
PMC: 10146995.
DOI: 10.3390/microorganisms11040895.
Diaphragmatic ultrasonography in patients with IPF: Is diaphragmatic structure and mobility related to fibrosis severity and pulmonary functional changes?.
Kalbaran Kismet G, Okutan O, Ayten O, Samanci C, Yesildal M, Kartaloglu Z
Tuberk Toraks. 2023; 71(1):13-23.
PMID: 36912405
PMC: 10795268.
DOI: 10.5578/tt.20239903.
A Telerehabilitation Program for Maintaining Functional Capacity in Patients With Chronic Lung Diseases During a Period of COVID-19 Social Isolation: Quasi-Experimental Retrospective Study.
Miozzo A, Righi N, Yumi Shizukuishi M, Marques Ferreira Aguilar H, Florian J, Machado S
JMIR Rehabil Assist Technol. 2022; 9(4):e40094.
PMID: 36473024
PMC: 9795598.
DOI: 10.2196/40094.
A qualitative exploration of people living with idiopathic pulmonary fibrosis experience of a virtual pulmonary rehabilitation programme.
OShea O, Murphy G, Forde L, OReilly K
BMC Pulm Med. 2022; 22(1):448.
PMID: 36443780
PMC: 9702935.
DOI: 10.1186/s12890-022-02221-6.
Number 2 Feibi Recipe Ameliorates Pulmonary Fibrosis by Inducing Autophagy Through the GSK-3β/mTOR Pathway.
Liu H, Pang Q, Cao F, Liu Z, Wei W, Li Z
Front Pharmacol. 2022; 13:921209.
PMID: 35903328
PMC: 9315309.
DOI: 10.3389/fphar.2022.921209.
Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary after COVID-19 Infection.
Ruggiero V, Aquino R, Del Gaudio P, Campiglia P, Russo P
Pharmaceutics. 2022; 14(6).
PMID: 35745708
PMC: 9229559.
DOI: 10.3390/pharmaceutics14061135.
Development and applicability of a dignity-centred palliative care programme for people with idiopathic pulmonary fibrosis: A qualitative-driven mixed methods study.
Igai Y, Porter S
Nurs Open. 2022; 10(1):8-23.
PMID: 35726124
PMC: 9748069.
DOI: 10.1002/nop2.1274.
Blueberry Juice Attenuates Pulmonary Fibrosis Blocking the TGF-β1/Smad Signaling Pathway.
Li Y, Wang L, Zhang Q, Tian L, Gan C, Liu H
Front Pharmacol. 2022; 13:825915.
PMID: 35418869
PMC: 8996108.
DOI: 10.3389/fphar.2022.825915.
Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?.
Guiot J, Henket M, Frix A, Gester F, Thys M, Giltay L
Respir Res. 2022; 23(1):89.
PMID: 35410260
PMC: 8996531.
DOI: 10.1186/s12931-022-02006-9.
Efficacy and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis patients: a systematic review and meta-analysis of randomised controlled trials.
Wu W, Qiu L, Wu J, Liu X, Zhang G
BMJ Open. 2022; 11(12):e050004.
PMID: 34972762
PMC: 8720994.
DOI: 10.1136/bmjopen-2021-050004.
Radiological and Physiological Predictors of IPF Mortality.
Kishaba T, Maeda A, Yamazato S, Nabeya D, Yamashiro S, Nagano H
Medicina (Kaunas). 2021; 57(10).
PMID: 34684158
PMC: 8537035.
DOI: 10.3390/medicina57101121.